Healthcare Services

Pyrogen Testing Market Revenue Expected to Reach $3.42 Billion by 2030 with 12.2% CAGR

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Pyrogen Testing Market At The End Of The 2026–2030 Forecast Period?

The pyrogen testing market has seen significant growth in recent years. It is anticipated to increase from $1.91 billion in 2025 to $2.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The expansion observed in the historic period is attributable to the expansion of pharmaceutical manufacturing capacity, increased production of injectable drugs and vaccines, regulatory mandates for pyrogen testing, reliance on LAL-based assays, and the growth of biologics development.

The pyrogen testing market is anticipated to experience substantial expansion over the upcoming years, with projections indicating it will reach $3.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This projected growth can be attributed to several factors, including the increasing adoption of rFC and MAT assays, a rise in investments in biopharmaceutical research and development, the expansion of cell and gene therapy manufacturing, a growing focus on animal-free testing solutions, and increased automation in quality control laboratories. Key trends expected within this forecast period involve the wider acceptance of recombinant and in vitro pyrogen tests, a noticeable shift away from animal-based testing methods, an increasing demand for rapid and high-sensitivity detection assays, the proliferation of automated endotoxin testing instruments, and a stronger emphasis on regulatory compliance in biopharmaceutical manufacturing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4020&type=smp

Which Market Drivers Are Supporting The Expansion Of The Pyrogen Testing Market?

The growing investments in research and development (R&D) by pharmaceutical and biotechnology companies are expected to drive the expansion of the **Pyrogen Testing Market** in the future. Pyrogen testing involves assessing drugs and biologics to confirm they are free from fever-inducing substances, such as endotoxins, which is vital for safe product manufacturing. The increase in R&D expenditure is driven by the necessity to create advanced therapies and biologics that demand strict quality control and safety evaluations. Pyrogen testing encourages increased R&D investments by guaranteeing the safety and regulatory compliance of new drugs and biologics, thus enabling pharmaceutical and biotechnology firms to confidently develop innovative treatments. For example, in February 2025, according to the **National Center for Science and Engineering Statistics (NCSES)**, a **US**-based government statistical agency, **U.S.** research and development expenditures climbed from **$892 billion** in **2022** to **$940 billion** in **2023**, marking an increase of **$48 billion**. Consequently, the rising R&D investments by pharmaceutical companies are propelling the growth of the **Pyrogen Testing Market**. The increasing incidence of tuberculosis (TB) is projected to stimulate the growth of the **Pyrogen Testing Market** moving forward. Tuberculosis is an infectious illness caused by the bacterium *Mycobacterium tuberculosis*, primarily affecting the lungs but capable of spreading to other organs, and it remains a leading cause of preventable death globally. The surge in TB cases is attributed to factors such as population expansion, urbanization, and gaps in healthcare access, leading to higher infection rates in vulnerable communities. Pyrogen testing contributes to pharmaceutical safety by ensuring that drugs and medical devices are devoid of fever-inducing contaminants, like bacterial endotoxins, thereby protecting patients. For instance, in May 2025, the **World Health Organization (WHO)**, a **Switzerland**-based health standards organization, reported that in **2023**, approximately **10.8 million** people worldwide developed TB, resulting in **1.25 million** fatalities. These figures underscore the escalating burden of a highly infectious disease and emphasize the critical need for stringent safety testing in pharmaceutical production. Therefore, the rising incidence of TB is fueling the growth of the **Pyrogen Testing Market**.

What Segment Types Make Up The Pyrogen Testing Market?

The pyrogen testing market covered in this report is segmented –

1) By Test Type: LAL Test, In Vitro Test, Rabbit Test

2) By Product And Service: Assays, Kits, And Reagents, Instruments, Services

3) By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications

Subsegments:

1) By Test Limulus Amebocyte Lysate (LAL) Test: Gel Clot LAL Test, Chromogenic LAL Test, Turbidimetric LAL Test

2) By In Vitro Test: Monocyte Activation Test (MAT), Recombinant Factor C (rFC) Assay, Other In Vitro Tests

3) By Rabbit Test: Pyrogen Test in Rabbits, Other Animal-Based Tests

Which Trends Are Impacting The Growth Of The Pyrogen Testing Market?

Leading companies in the pyrogen testing market are engaged in developing innovative products, such as sustainable monocyte activation test (MAT) systems, to enhance their business offerings and expand market reach. The monocyte activation test (MAT) System is an in vitro assay utilized for pyrogen testing within the biopharmaceutical and medical device industries. For instance, in October 2023, Lonza, a Swiss multinational manufacturing firm, introduced two new rapid monocyte activation test (MAT) systems: the PyroCell MAT Rapid System and the PyroCell MAT Human Serum (HS) Rapid System. These systems are set to replace Lonza’s existing MAT system kit offerings and include the new PeliKine Human IL-6 Rapid ELISA Kit, which minimizes hands-on time and shortens the time-to-results from two days to two hours. The new tests offer pharmaceutical manufacturers more accessible, quicker, and more efficient MAT testing alternatives for product safety, while also contributing to reducing reliance on animal testing.

Who Are The Key Players Driving Competition In The Pyrogen Testing Market?

Major companies operating in the pyrogen testing market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group Ltd., Ellab A S, Nelson Laboratories LLC, Associates of Cape Cod Inc., GenScript Biotech Corporation, bioMerieux SA, Hyglos GmbH, Wako Chemicals USA Inc., Pyrostar International Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Group, Sigma Aldrich Co. LLC, Bio Rad Laboratories Inc., Microcoat Biotechnologie GmbH, Sartorius AG, Pacific Biolabs Inc., Toxikon Corporation, STERIS Corporation, Avance Biosciences Inc., BioReliance Corporation, Microbiological Consulting LLC, Microbac Laboratories Inc., North American Science Associates Inc., Pace Analytical Life Sciences LLC

Read the full pyrogen testing market report here:

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

How Is The Pyrogen Testing Market Distributed Across Key Geographic Regions?

North America was the largest region in the pyrogen testing market in 2025. Asia-Pacific is expected to continue to be the fastest growing region in the pyrogen testing market share during the forecast period. The regions covered in the pyrogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pyrogen Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4020&type=smp

Browse Through More Reports Similar to the Global Pyrogen Testing Market 2026, By The Business Research Company

Structural Insulated Panels Market

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Automotive Shielding Global Market Report

https://www.thebusinessresearchcompany.com/report/automotive-shielding-global-market-report

Metal Structural Insulation Panels Global Market Report

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795